BAMCO Inc

BAMCO Inc’s Juno Therapeutics, Inc. JUNO Stock Holding History

BAMCO Inc’s Portfolio JUNO Stock Details JUNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-443,107	Closed	-$13.3M	–	342
2016 Q3	$13.3M	Buy	443,107 +342,582	+341%	+$10.7M	0.07%	184
2016 Q2	$3.86M	Buy	+100,525	New	+$4.17M	0.02%	220
2016 Q1	–	Sell	-200,000	Closed	-$8.79M	–	327
2015 Q4	$8.79M	Hold	200,000	–	–	0.04%	215
2015 Q3	$8.14M	Buy	+200,000	New	+$8.77M	0.04%	222
2015 Q1	–	Sell	-35,000	Closed	-$1.83M	–	375
2014 Q4	$1.83M	Buy	+35,000	New	+$1.57M	0.01%	296

Other funds holding JUNO

Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return

Baillie Gifford & Co

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Biomark Capital Management Greenwich, Connecticut $8.9M AUM 97.06% 1-Year Est. Return

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return